What are Analysts opinions on Radius Health, Inc.(NASDAQ:RDUS): Moelis & Company(NYSE:MC)

0
6

Radius Health, Inc. (RDUS) will report its next earnings on Feb 28 AMC. The company reported the earnings of $-0.9/Share in the last quarter where the estimated EPS by analysts was $-1.17/share. The difference between the expected and actual EPS was $0.27/share, which represents an Earnings surprise of 23.1%.

Many analysts are providing their Estimated Earnings analysis for Radius Health, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $-0.9/share. These analysts have also projected a Low Estimate of $-1.2/share and a High Estimate of $-0.66/share.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for Radius Health, Inc. as 35.21 Million. According to these analysts, the Low Revenue Estimate for Radius Health, Inc. is 33 Million and the High Revenue Estimate is 37.5 Million. The company had Year Ago Sales of 14.55 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for RDUS to be 30.7%. They are projecting Next Quarter growth of 2.02%. For the next 5 years, Radius Health, Inc. is expecting Growth of 27.72% per annum, whereas in the past 5 years the growth was -1.67% per annum.

Some buy side analysts are also providing their Analysis on Radius Health, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Radius Health, Inc. might touch $46 high while the Average Price Target and Low price Target is $33.25 and $19 respectively.

Radius Health, Inc. closed its last trading session at $22.22 with the loss of -0.32%. The Market Capitalization of the company stands at 1 Billion. The Company has 52-week high of $36.94 and 52-week low of $12.81. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 10.96% where SMA50 and SMA200 are 14.91% and 12.78% respectively. The Company Touched its 52-Week High on 04/12/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.62 and Average Volume (3 months) is 579.05 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -64.7%. The Return on Equity (ROE) value stands at -181.6%. While it’s Return on Investment (ROI) value is -84.9%.

While looking at the Stock’s Performance, Radius Health, Inc. currently shows a Weekly Performance of -0.63%, where Monthly Performance is 14.23%, Quarterly performance is 33.51%, 6 Months performance is 17.57% and yearly performance percentage is -39.28%. Year to Date performance value (YTD perf) value is 34.32%. The Stock currently has a Weekly Volatility of 3.76% and Monthly Volatility of 4.73%.

Moelis & Company (MC) will report its next earnings on May 08 AMC. The company reported the earnings of $0.77/Share in the last quarter where the estimated EPS by analysts was $0.67/share. The difference between the expected and actual EPS was $0.1/share, which represents an Earnings surprise of 14.9%.

Many analysts are providing their Estimated Earnings analysis for Moelis & Company and for the current quarter 9 analysts have projected that the stock could give an Average Earnings estimate of $0.46/share. These analysts have also projected a Low Estimate of $0.12/share and a High Estimate of $0.79/share.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for Moelis & Company as 192.87 Million. According to these analysts, the Low Revenue Estimate for Moelis & Company is 143.12 Million and the High Revenue Estimate is 235 Million. The company had Year Ago Sales of 219.42 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for MC to be -23.1%. They are projecting Next Quarter growth of -2.56%. For the next 5 years, Moelis & Company is expecting Growth of 14.76% per annum, whereas in the past 5 years the growth was 0.72% per annum.

Some buy side analysts are also providing their Analysis on Moelis & Company, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Moelis & Company might touch $56 high while the Average Price Target and Low price Target is $49.56 and $45 respectively.

Moelis & Company closed its last trading session at $39.02 with the loss of -0.08%. The Market Capitalization of the company stands at 2.2 Billion. The Company has 52-week high of $64.27 and 52-week low of $31.78. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -7.04% where SMA50 and SMA200 are -10.19% and -16.78% respectively. The Company Touched its 52-Week High on 06/20/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.63 and Average Volume (3 months) is 529.94 million. The company’s P/E (price to earnings) ratio is 13.96 and Forward P/E ratio of 12.17.

The company shows its Return on Assets (ROA) value of 18.2%. The Return on Equity (ROE) value stands at 38%. While it’s Return on Investment (ROI) value is 48.5%.

While looking at the Stock’s Performance, Moelis & Company currently shows a Weekly Performance of -7.56%, where Monthly Performance is -11.27%, Quarterly performance is 8.05%, 6 Months performance is -24.44% and yearly performance percentage is -20.69%. Year to Date performance value (YTD perf) value is 16.56%. The Stock currently has a Weekly Volatility of 2.44% and Monthly Volatility of 2.91%.

SHARE